Full Length Research Paper
References
|
Adam J, Scott J (2000). Predicting medication adherence in severe mental disorders. Acta. Psychiatr. Scand. 101:119-124. crossref |
||||
|
Adeponle AB, Thombs BD, Adelekan ML, Kirmayer LJ (2009). Family participation in treatment, post discharge appointment and medication adherence at a Nigerian psychiatric hospital. Br. J. Psychiatry 194:86-87. crossref |
||||
|
Adewuya AO, Owoeye OA, Erinfolami AR, Coker AO, Ogun OC, Okewole AO, Dada MU, Eze CN, Bello-Mojeed MA, Akindipe TO, Olagunju AT, Etim E. (2009). Prevalence and correlates of poor medication adherence amongst psychiatric patients in South-western Nigeria. Gen. Hosp. Psychiatry 31(2):167-174. crossref |
||||
| Aloba O, Fatoye O, Mapayi B, Akinsulore S (2013). A review of quality of life studies among Nigerian patients with psychiatric disorders. Afr. J. Psychiatry 16:333-337. | ||||
| American Pharmacists Association (2013). Improving medication adherence in patients with severe mental illness. Pharmacy Today 19(6):69-80. | ||||
| Amr M, El-Mogy A, El-Masry R (2013). Adherence in Egyptian patients with schizophrenia: the role of insight, medication beliefs and spirituality. Arab J. Psychiatry 24(1):60-68. | ||||
|
Baldessarini R, Henk H, Sklar A, Chang J, Leahy L (2008). Psychotropic medications for patients with bipolar disorder in the United States: Polytherapy and Adherence. Psychiatr. Serv. 59(10):1175-1183. crossref |
||||
|
Baldessarini RJ, Perry R, Pike J (2008). Factors associated with treatment nonadherence among US bipolar disorder patients. Hum. Psychopharmacol. 23(2):95-105. crossref |
||||
|
Banerjee S, Varma RP (2013). Factors affecting non-adherence among patients diagnosed with unipolar depression in a psychiatric department of a tertiary hospital in Kolkata, India. Depress. Res. Treat. 1-12. crossref |
||||
|
Barnes TR, Schizophrenia Consensus Group of the British Association of Psychopharmacology (2011). Evidence-based guidelines for the pharmacological treatment of schizophrenia: Recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 25(5):567-620. crossref |
||||
|
Caldeira D, Vaz-carneiro A, Costa J (2014). The impact of dosing frequency on medication adherence in chronic cardiovascular disease: Systematic review and meta-analysis. Rev. Port. Cardiol. 33(7-8):431-437. crossref |
||||
|
Chesney MA (2000). Factors affecting adherence to antiretroviral therapy. Clin. Infect. Dis. 30(2):171-6. crossref |
||||
|
Danladi J, Kakjing D. Falang, Raymond A. Barde, Nanlok S. Jimam, Dauda A. Dangiwa, Hafsat O. Jimoh (2013). Pharmaceutical care and medication adherence in management of psychosis in a Nigerian tertiary hospital. J. Res. Pharm. Pract. 2(2):83-87. crossref |
||||
|
Demoz Z, Legesse B, Teklay G, Demeke B, Eyob T, Shewamene Z, Abera M (2014). Medication adherence and its determinants among psychiatric patients in an Ethiopian referral hospital. Patient Prefer. Adherence 8:1329-1335. Pubmed |
||||
|
DiBonaventura M, Gabriel S, Dupclay L, Gupta S, Kim E (2012). A patient perspective of the impact of medication side effects to adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry 12:20. crossref |
||||
|
Dilla T, Ciudad A, Alvarez M (2013). Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Prefer. Adherence 7:275-284. crossref |
||||
|
Eticha T, Teklu A, Ali D, Solomon G (2015). Factors associated medication adherence among patients with schizophrenia in Mekelle. PLoS ONE 10(3):e0120560. crossref |
||||
| George D, Mallery P (2003). SPSS for windows step by step: a simple guide and reference. 11.0 update (4th edn) Boston: Allyn and Bacon. | ||||
| Goodwin GM, Consensus group of the British Association of Psychopharmacology (2009). Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 23(4):346-388. | ||||
|
Harding CM, Brooks GW, Ashikaga T, Strauss JS, Breier A (1987). The Vermont Longitudinal study of persons with severe mental illness, I: Methodology, Study sample, and Overall Status 32 years later. Am. J. Psychiatry 144(6):718-726. crossref |
||||
|
Hauber AB, Han S, Yang JC, Gantz I, Tunceli K, Gonzalez JM, Brodovicz K, Alexander CM, Davies M, Iglay K, Zhang Q, Radican L (2013). Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer. Adherence 7:937 - 949. crossref |
||||
|
Higashi K, Medic G, Littlewood KJ, Diez T, Granstrom O, De Hert M (2013). Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther. Adv. Psychopharmacol. 3(4):200-218. crossref |
||||
|
Kane JM, Kishimoto T, Correll CU (2013). Non-adherence to medications in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry 12:216-226. crossref |
||||
| Kassis IT, Ghuloum S, Mousa H, Bener A (2014). Treatment non-compliance of psychiatric patients; are patients satisfied from their psychiatrist? Br. J. Med. Med. Res. 4(2):785 - 796. | ||||
|
Keck PE Jr, McElroy SL, Strakowski SM, Stanton SP, Kizer DL, Balistreri TM, Bennett JA, Tugrul KC, West SA. (1996). Factors associated with pharmacologic noncompliance in patients with mania. J. Clin. Psychiatry 57:292-297. Pubmed |
||||
|
Kretchy IA, Owusu-Daaku FT, Danquah SA (2014). Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int. J. Ment. Health Syst. 8(25):1-6. crossref |
||||
|
Lacro JP, Dunn LB, Dolder CR, Leckband SG, Veste DV (2002). Prevalence of and risk factors for medication nonadherence in Patients with Schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 63(10): 892-909. crossref |
||||
|
Latalova K, Prasko J, Diveky T, Kamaradova D, Verlatova H (2011). Quality of life in patients with bipolar disorder - A comparison with schizophrenic and healthy controls. Psychiatr. Danub. 23(1):21-26. Pubmed |
||||
|
Morisky DE, Ang A, Krousel-Wood M, Ward H (2008). Predictive validity of a Medication adherence measure for hypertension control. J. Clin. Hypertens.10(5):348-354. crossref |
||||
| National Bureau of Statistics (NBS) (2013). Revised poverty statistics. NBS, Abuja. | ||||
|
Okpataku CI, Kwanashie HO, Ejiofor JI, Olisah VO (2015). Medication compliance behavior in psychiatric out-patients with psychoactive substance use comorbidity in a Nigerian tertiary hospital. Niger. J. Clin. Pract. 18(3):371-376. crossref |
||||
|
Pfeiffer PN, Ganoczy D, Valenstein M (2008). Dosing frequency and medication adherence to antipsychotic medications. Psychiatr. Serv. 59(10):1207-1210. crossref |
||||
|
Razzouk D, Kayo M, Sousa A, Gregorio G, Cogo-Moreira H, Cardoso AA, Mari Jde J. (2015). The impact of antipsychotic polytherapy in the public health care in Sao-Paolo, Brazil. PLoS ONE 10(4):e0124791. crossref |
||||
|
Rietschel M, Georgi A, Schmael C, Schirmbeck F, Strohmaier J, Boesshenz KV, Schwarz M, Nöthen MM, Schulze TG. (2009). Premorbid adjustment: a phenotype highlighting a distinction rather than an overlap between schizophrenia and bipolar disorder. Schizophr. Res. 110:33-39. crossref |
||||
|
Saarni SI, Viertio S, Perala J, Koskinen S, Lonnqvist J, Suvisaari J (2010). Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br. J. Psychiatry 197:386-394. crossref |
||||
|
Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV (2006). Treatment adherence with antipsychotic medications in bipolardisorder. Bipolar. Disord. 8(3):232-241. crossref |
||||
|
Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV (2007). Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr. Serv. 58(6):855-863. crossref |
||||
| United Nations Development Group (2003). Indicators for monitoring the millennium development goals: definitions, rationale, concepts and sources. United Nations. October 2003; New York NY, 10017. | ||||
| United Nations Development Programme (2013). Nigerian Millennium Development Goals Report. 2013. Available at: www.mdgs.gov.ng on van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J (2007). Patient adherence to treatment: a review of reviews. BMC Health Serv. Res. 7(55): 1 - 13. | ||||
|
Weiden PL, Miller AL (2001). Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. J. Psychiatr. Pract. 7(1):4 -47. crossref |
||||
|
Yang J, Ko YH, Paik JW, Lee MS, Han C, Joe SH, Jung IK, Jung HG, Kim SH. (2012). Symptom severity and attitudes towards medication: impacts on adherence in outpatients with schizophrenia. Schizophr. Res. 134(2-3):226-31. crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
